NRX Pharmaceuticals Inc.

05/26/2022 | Press release | Distributed by Public on 05/25/2022 22:12

NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. National Institutes of Health (NIH) Study of ZYESAMI® (aviptadil) in Critical COVID-19

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.